Simon De Meyer
After finishing his master studies of Industrial Engineering and of Bio-engineering, Simon De Meyer obtained his PhD in Biochemistry in 2005 at the Laboratory for Thrombosis Research of KU Leuven Kulak in Kortrijk, Belgium. During his PhD, he focused on the development of gene therapy for von Willebrand disease as well as on the inhibition of platelet adhesion to reduce restenotic events after arterial stenting. In 2006, he obtained an FWO (Fonds voor Wetenschappelijk Onderzoek Vlaanderen) postdoctoral fellowship to continue his work in the Laboratory for Thrombosis Research. In 2009, Dr. De Meyer took a post-doctoral research position at Harvard University (Immune Disease Institute in the laboratory of Prof. Denisa Wagner, Boston, US) where he further developed his interest in the pathophysiology of myocardial and cerebral ischemia/reperfusion injury. He returned to the Laboratory for Thrombosis Research to take an associate professorship at the Faculty of Biomedical Sciences at KU Leuven Kulak in 2012. Since then, he is leading his own research team with a focus on the thrombo-inflammatory aspects of the VWF/ADAMTS13/platelet axis in health and disease.
Simon De Meyer is (co)author of some 120 papers in international peer reviewed journals and is co-owner of 4 patents. An up-to-date list of publications can be found via Pubmed , Lirias or Orcid.
Academic positions
2001-2005: PhD-student, IWT, Laboratory for Thrombosis Research, KU Leuven Campus Kortrijk (Prof. Dr. H. Deckmyn)
2006-2012: Postdoctoral researcher, FWO, Laboratory for Thrombosis Research, KU Leuven Campus Kortrijk (Prof. Dr. H. Deckmyn, Prof. Dr. K. Vanhoorelbeke)
2009-2011: Postdoctoral Research Fellow in Pathology, Harvard Medical School, Boston, USA
2009-2011: Postdoctoral Research Fellow, Immune Disease Institute, Boston, USA (Prof. Dr. D.D. Wagner)
2012-2017: Assistant Professor at KU Leuven
2013-2018: Member of Young Academy of Belgium
2015-present: Board member of the Belgian Society of Thrombosis and Haemostasis
2015-2023: chair/dean of Biomedical Sciences Group/Faculty of Medicine, KU Leuven campus Kulak Kortrijk
2017-present: Associate Professor KU Leuven
Honors and Awards
2007: Young Investigator Award, XXIst Congress of the International Society on Thrombosis and Haemostasis, Geneva, Switzerland
2009: Young Investigator Award on the XXIInd Congress of the International Society on Thrombosis and Haemostasis, Boston, USA
2010: Bayer Hemophilia Early Career Investigator Award, Bayer Hemophilia Awards Program, Buenos Aires, Argentina
2010: Sanofi-Aventis Prize for Research in Thrombosis, Haemostasis, Vascular Biology and Experimental Cardiology (three-annual), Ghent, Belgium
2011: U.S. New Investigator Award on the XXIIIrd Congress of the International Society on Thrombosis and Haemostasis, Kyoto, Japan
2012: Galenus Prize for Fundamental Pharmacology (three-annual), Brussels, Belgium
2013: Prize Edmond Secq/André Houssiau for the study of hereditary bleeding disorders, Royal Academy for Medicine of Belgium, Brussels, Belgium (together with Karen Vanhoorelbeke)
2017: Baron Marc Verstraete Prize for research on hemato-angiology (Royal Academy for Medicine of Belgium)
2019: Prize Ernest Solvay in Neurological Sciences (Queen Elisabeth Medical Foundation for Neurosciences), Brussels, Belgium, 2019 (awarded by H.R.H. Princess Astrid of Belgium)